Two different compounds (pictured above) were generated using zinc (left) and manganese (right). Whilst these two compounds ‘look’ very similar the zinc compound demonstrated excellent anti-cancer activity and selectivity towards a range of cancers in the laboratory whereas the manganese compound was comparatively much more toxic, meaning there was more anti-cancer activity at a lower concentration, with similar selectivity compared to current drugs tested.
A team of scientists at the University of Huddersfield has discovered chemical systems that self-assemble into molecular capsules which are highly toxic towards human cancer cells of a range of different tumour types, and which have demonstrated unprecedented cancer selectivity in the laboratory that, in some cases, are many thousands of times more toxic to the cancer cells compared to healthy, normal cells
ONE of the most challenging aspects of cancer treatment is the huge variety of different tumours that can occur with each one potentially requiring a different solution because unfortunately, one drug does NOT fit all. In addition, another major issue of many current drugs is their poor selectivity towards cancers resulting in problems such as normal tissue toxicity, severe side effects and the development of drug resistance.
Now, a team of scientists at the University of Huddersfield is researching how to combat these challenges by using “self-assembled” drugs and although the research is in its very early stages, they’ve already had a breakthrough.
The science behind self-assembly
Self-assembly is the ability to instruct chemical systems with specific information so in the correct environment they will spontaneously generate biologically active compounds. Using this process many different compounds can be rapidly and easily formed with each different self-assembled drug having different chemotherapy properties.
“In the future, it may be possible to target many cancers through this approach with the correct drug ‘self-assembled’ in such a manner to be selective for a specific cancer.”
Professor Craig Rice
In an article published by the journal Nature Communications, the University’s Professor Roger Phillips, Dr Simon Allison and Professor Craig Rice demonstrate chemical systems that self-assemble into molecular capsules which are highly toxic towards human cancer cells of a range of different tumour types.
More importantly, they show unprecedented cancer selectivity in the laboratory that, in some cases, are many thousands of times more toxic to the cancer cells compared to healthy, normal cells.
Cancer therapy without severe side-effects
Eventually, if similar results are obtained in more complex testing systems including in patients, and once considered safe after careful testing, it could offer the possibility of being able to treat cancers without the severe side effects commonly associated with chemotherapy drugs.
“Anti-cancer drug discovery and development can be enormously time consuming and expensive with a particular drug only being effective against a relatively small number of cancers with specific shared properties,” explained Professor Rice who heads the University’s Department of Chemical Sciences and is also the Director of the Structural, Molecular and Dynamic Modelling Centre within the School of Applied Sciences.
“In the future, it may be possible to target many cancers through this approach with the correct drug ‘self-assembled’ in such a manner to be selective for a specific cancer,” said Professor Rice.
Targeting hard-to-treat cancers
The research could also pave the way in targeting hard-to-treat cancers for which commonly used chemotherapy drugs have little or no effect.
The published studies show the new potential drug can be assembled with either zinc, copper, or manganese, with the three metal ions imparting significantly different chemotherapeutic properties via different mechanisms dependent upon which metal ion is used.
“It is this which allows the generation of different chemical systems each of which may have specificity for different cancers,” he said.
Original Article: Cancer therapy breakthrough in vitro using self-assembled drugs
More from: University of Huddersfield
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Self-assembled drugs
- California lawmakers advance over a dozen bills to combat state’s fentanyl crisis
Lawmakers have advanced several bills to combat California’s fentanyl crisis. While Democrats want to focus on prevention and treatment, Republicans want to enforce harsher punishments.
- California advances fentanyl bills focused on prevention, increased penalties
California lawmakers voted to advance more than a dozen fentanyl bills this past week SACRAMENTO, Calif. -- California lawmakers have advanced more than a dozen bills aiming to address the fentanyl ...
- California advances fentanyl bills on prevention, increased penalties
California lawmakers advanced more than a dozen bills aiming to address the fentanyl crisis, including some that would impose harsher prison sentences for de ...
- 'We now understand very clearly the harm that is caused': Call to decriminalise drug users
Campaigners say criminalising people who use drugs causes them additional harm and imposes a significant cost on the State ...
- Spooked by crime, Ecuadoreans train to carry guns for self-defense
Spurred by rising violent crime and increased gang activity, a growing number of Ecuadoreans are learning to use guns in the hope of protecting themselves from crime, four firearm instructors and ...
Go deeper with Google Headlines on:
Self-assembled drugs
[google_news title=”” keyword=”self-assembled drugs” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Cancer therapy without severe side-effects
- Ask an expert: Can radiation burns cause sepsis in patients battling cancer?
Radiation treatment is recommended in patients of some cancers. Radiation treatment is usually painless but it can cause serious side effects to other healthy ... that is why cancer patents skin ...
- 'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues, reducing treatment side effects
Though it was discovered more than 30 years ago, IL-12 still isn’t an FDA-approved therapy for cancer patients because of its severe side effects, such as liver damage ... strong immune response ...
- Kisqali Plus Endocrine Therapy Improves Early Breast Cancer Outcomes
Adding Kisqali to endocrine therapy tended to improve the amount of time patients with HR-positive, HER2-negative early breast cancer lived before their disease became invasive.
- New approach improves cancer treatment and minimizes side effects
Scientists have discovered a new approach to improve the efficacy of immune checkpoint blockade while minimizing the associated side effects.
- Limited Supply of Cancer Drugs and the Impact on Patient Care
The United States Food and Drug Administration (FDA) tracks drugs experiencing shortages, preventing doctors from getting the best drugs to treat their pat | Cancer ...
Go deeper with Google Headlines on:
Cancer therapy without severe side-effects
[google_news title=”” keyword=”Cancer therapy without severe side-effects” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
